Literature DB >> 23280020

The anticancer mechanism of caffeic acid phenethyl ester (CAPE): review of melanomas, lung and prostate cancers.

G Ozturk1, Z Ginis, S Akyol, G Erden, A Gurel, O Akyol.   

Abstract

BACKGROUND: Caffeic acid phenethyl ester (CAPE), an active component of propolis extract, specifically inhibits NF-κB. It exhibits antioxidant, antiinflammatory, antiproliferative, cytostatic, and most importantly, antineoplastic properties. AIM: The aim of the present mini-review is to summarize and evaluate the anticancer mechanism of CAPE with examples of several cancer types.
RESULTS: In view of the mechanisms and findings in our laboratory and those of others in literature, we suggest that CAPE possess anticancer and apoptosis inducing activities.
CONCLUSIONS: Further researches are needed regarding the anticancer basis of CAPE in all disciplines of medicine. Also, clinical potential toxicities of CAPE should be revealed if it is going to be used as an anticancer agent.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23280020

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  34 in total

1.  Crystal Engineering Construction of Caffeic Acid Derivatives with Potential Applications in Pharmaceuticals and Degradable Polymeric Materials.

Authors:  Zhihan Wang; Quinton Flores; Hongye Guo; Raquel Trevizo; Xiaochan Zhang; Shihan Wang
Journal:  CrystEngComm       Date:  2020-10-26       Impact factor: 3.545

2.  Long noncoding RNA-SRLR elicits intrinsic sorafenib resistance via evoking IL-6/STAT3 axis in renal cell carcinoma.

Authors:  Z Xu; F Yang; D Wei; B Liu; C Chen; Y Bao; Z Wu; D Wu; H Tan; J Li; J Wang; J Liu; S Sun; L Qu; L Wang
Journal:  Oncogene       Date:  2016-11-14       Impact factor: 9.867

3.  Caffeic acid phenethyl ester exerts apoptotic and oxidative stress on human multiple myeloma cells.

Authors:  Elizabeth Hernandez Marin; Hana Paek; Mei Li; Yesung Ban; Marie Katie Karaga; Rangaiah Shashidharamurthy; Xinyu Wang
Journal:  Invest New Drugs       Date:  2018-11-22       Impact factor: 3.850

4.  Antifilarial activity of caffeic acid phenethyl ester on Brugia pahangi in vitro and in vivo.

Authors:  Nazeh M Al-Abd; Zurainee Mohamed Nor; Quazim O Junaid; Marzida Mansor; M S Hasan; Mustafa Kassim
Journal:  Pathog Glob Health       Date:  2017-10-25       Impact factor: 2.894

5.  Synthesis, antitumor activity, and mechanism of action of 6-acrylic phenethyl ester-2-pyranone derivatives.

Authors:  Sai Fang; Lei Chen; Miao Yu; Bao Cheng; Yongsheng Lin; Susan L Morris-Natschke; Kuo-Hsiung Lee; Qiong Gu; Jun Xu
Journal:  Org Biomol Chem       Date:  2015-04-28       Impact factor: 3.876

6.  PT93, a novel caffeic acid amide derivative, suppresses glioblastoma cells migration, proliferation and MMP-2/-9 expression.

Authors:  Kaishu Li; Yalin Tu; Qingyu Liu; Ying Ouyang; Mingliang He; Ming Luo; Jingkao Chen; Rongbiao Pi; Anmin Liu
Journal:  Oncol Lett       Date:  2017-02-01       Impact factor: 2.967

7.  Caffeic acid phenethyl ester inhibits pseudo-allergic reactions via inhibition of MRGPRX2/MrgprB2-dependent mast cell degranulation.

Authors:  Nisha Adhikari; Won-Sik Shim
Journal:  Arch Pharm Res       Date:  2022-10-02       Impact factor: 6.010

8.  Propolis reduces the stemness of head and neck squamous cell carcinoma.

Authors:  Felipe Nör; Carolina Nör; Letícia W Bento; Zhaocheng Zhang; Walter A Bretz; Jacques E Nör
Journal:  Arch Oral Biol       Date:  2021-02-19       Impact factor: 2.633

Review 9.  Inhibitory effect of polyphenols (phenolic acids, lignans, and stilbenes) on cancer by regulating signal transduction pathways: a review.

Authors:  A Hazafa; M O Iqbal; U Javaid; M B K Tareen; D Amna; A Ramzan; S Piracha; M Naeem
Journal:  Clin Transl Oncol       Date:  2021-10-05       Impact factor: 3.405

10.  Cytotoxic effects of caffeic acid undecyl ester are involved in the inhibition of telomerase activity in NALM-6 human B-cell leukemia cells.

Authors:  Ayako Tomizawa; Syu-Ichi Kanno; Yuu Osanai; Shin Yomogida; Masaaki Ishikawa
Journal:  Oncol Lett       Date:  2013-07-23       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.